Anzeige
Meldung des Tages: NASDAQ, Washington, Psychedelika – und Optimi steht im Zentrum der Explosion

Day One Biopharmaceuticals News

Aktie
WKN:  A3CQ56 ISIN:  US23954D1090 US-Symbol:  DAWN Branche:  Biotechnologie Land:  USA
21,475 $
+0,015 $
+0,07%
18,245 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
809,59 Mio. €
Streubesitz
-
KGV
-9,63
Index-Zuordnung
-

Day One Biopharmaceuticals News

09.04.26 - PR Newswire
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? PR Newswire
27.03.26 - PR Newswire
Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders?
Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders? PR Newswire
19.03.26 - PR Newswire
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care PR Newswire
12.03.26 - PR Newswire
Are DAWN, TALK, UNF Obtaining Fair Deals for their Shareholders?
Are DAWN, TALK, UNF Obtaining Fair Deals for their Shareholders? PR Newswire
11.03.26 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--DAWN, SEM, FONAR, and JHG
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--DAWN, SEM, FONAR, and JHG PR Newswire
09.03.26 - PR Newswire
Are DAWN and TALK Obtaining Fair Deals for their Shareholders?
Are DAWN and TALK Obtaining Fair Deals for their Shareholders? PR Newswire
06.03.26 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire
06.03.26 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) PR Newswire
06.03.26 - PR Newswire
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr 0,00%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »